The ROE as of September 2024 (TTM) for Evaxion Biotech A/S (EVAX) is 67.25%

According to Evaxion Biotech A/S’s latest financial reports and current stock price. The company's current ROE is 67.25%. This represents a change of -177.82% compared to the average of -86.42% of the last 4 quarters.

Evaxion Biotech A/S (EVAX) Historical ROE (quarterly & annually)

How has EVAX ROE performed in the past?

The mean historical ROE of Evaxion Biotech A/S over the last ten years is 115.81%. The current 67.25% ROE has changed -41.93% with respect to the historical average. Over the past ten years (40 quarters), EVAX's ROE was at its highest in in the December 2023 quarter at 96.43%. The ROE was at its lowest in in the June 2024 quarter at -494.28%.

Evaxion Biotech A/S (EVAX) ROE by Quarter and Year

Discovering the peaks and valleys of Evaxion Biotech A/S ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Evaxion Biotech A/S (EVAX) Average ROE

How has EVAX ROE performed in the past?

The current ROE of Evaxion Biotech A/S (EVAX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Evaxion Biotech A/S (EVAX) ROE vs. Peers

How is EVAX’s ROE compared to its peers?

Evaxion Biotech A/S’s ROE is greater than Sigilon Therapeutics, Inc. (-81.98%), less than Reviva Pharmaceuticals Holdings, Inc. (7.96%), greater than ZyVersa Therapeutics, Inc. (-172.51%), less than Kiromic BioPharma, Inc. (337.72%), less than Unicycive Therapeutics, Inc. (294.74%), greater than Quoin Pharmaceuticals, Ltd. (-112.11%), greater than Allarity Therapeutics, Inc. (-704.78%), greater than Virax Biolabs Group Limited (-115.10%), greater than Biodexa Pharmaceuticals Plc (-141.90%), greater than Lyell Immunopharma, Inc. (-33.35%), greater than Cullinan Oncology, Inc. (-28.37%), greater than Monte Rosa Therapeutics, Inc. (-70.40%), greater than Theseus Pharmaceuticals, Inc. (-24.51%), greater than Revolution Medicines, Inc. (-34.57%), less than eFFECTOR Therapeutics, Inc. (2.18%), greater than Landos Biopharma, Inc. (-73.00%), greater than Apexigen, Inc. (-606.56%), greater than Navidea Biopharmaceuticals, Inc. (-63.06%), greater than Angion Biomedica Corp. (-113.71%), greater than Revelation Biosciences, Inc. (-243.91%), greater than Zura Bio Limited (-35.45%), greater than Phio Pharmaceuticals Corp. (-142.68%), greater than TransCode Therapeutics, Inc. (-597.47%),

Build a custom stock screener for Evaxion Biotech A/S (EVAX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Evaxion Biotech A/S using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Evaxion Biotech A/S (EVAX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Evaxion Biotech A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.